Featured
Vibrant and Healthy Kids: Aligning Science, Practice, and Policy to Advance Health Equity
Case Studies from the Action Collaborative on Clinician Well-Being and Resilience!
News
NAM Special Publication Examines How Understanding Heterogeneous Treatment Effects Can Lead to More Personalized Patient Care
Evidence-based medicine arose from a clear need and represents a major advance in the science of clinical decision-making. Despite broad acceptance of evidence-based medicine, however, a fundamental issue remains unresolved: evidence is derived from groups of people,...
Dr. Victor Dzau Gives Opening Remarks at the First Meeting of the International Commission on the Clinical Use of Human Germline Genome Editing
This morning, NAM President Dr. Victor J. Dzau gave opening remarks at the first meeting of the International Commission on the Clinical Use of Human Germline Genome Editing in Washington, D.C. The commission has been convened by the U.S. National Academy of Medicine...
New Case Studies Offer Actionable Insights to Reduce Clinician Burnout and Improve Well-Being
Clinicians of all kinds, across all specialties and care settings, are experiencing alarming rates of burnout. New case studies from the National Academy of Medicine’s (NAM) Action Collaborative on Clinician Well-Being and Resilience provide an overview of initiatives...
Six Health Professionals Selected for Robert Wood Johnson Foundation Health Policy Fellows Program at the National Academy of Medicine
The National Academy of Medicine (NAM) and Robert Wood Johnson Foundation (RWJF) today named the 2019-2020 class of RWJF Health Policy Fellows. Beginning in September, six health professionals will spend a year in Washington, D.C., working on health-related...
Featured Publication
Caring for the Individual Patient: Understanding Heterogeneous Treatment Effects
A Special Publication from the National Academy of Medicine
Evidence-based medicine arose from a clear need and represents a major advance in the science of clinical decision-making. Despite broad acceptance of evidence-based medicine, however, a fundamental issue remains unresolved: evidence is derived from groups of people, yet medical decisions are made by and for individuals. For evidence to be more applicable to individual patients, we need to combine methods for strong causal inference (first and foremost, randomization) with methods for prediction that permit inferences about which patients are likely to benefit and which are not. Better population-based outcomes will only be realized when we understand more completely how to treat patients as the unique individuals they are.
